Invesco Exchange-Traded Fund Trust. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Bio-Techne Corp.TECH | 2.13% | $16.31M | 226,188 |
| IQVIA Holdings Inc.IQV | 2.00% | $15.33M | 65,238 |
| Baxter International Inc.BAX | 1.99% | $15.29M | 584,473 |
| Regeneron Pharmaceuticals, Inc.REGN | 1.96% | $15.05M | 19,739 |
| Mettler-Toledo International Inc.MTD | 1.94% | $14.90M | 10,518 |
| Charles River Laboratories International, Inc.CRL | 1.93% | $14.82M | 63,739 |
| Veeva Systems Inc.VEEV | 1.93% | $14.78M | 72,510 |
| DaVita Inc.DVA | 1.87% | $14.35M | 59,771 |
| Moderna, Inc.MRNA | 1.85% | $14.15M | 258,109 |
| Thermo Fisher Scientific Inc.TMO | 1.84% | $14.13M | 24,599 |
| Abbott LaboratoriesABT | 1.83% | $14.07M | 133,066 |
| Bristol-Myers Squibb Co.BMY | 1.82% | $13.95M | 213,534 |
| Universal Health Services, Inc.UHS | 1.80% | $13.80M | 81,941 |
| Labcorp Holdings Inc.LH | 1.78% | $13.66M | 44,184 |
| Quest Diagnostics Inc.DGX | 1.77% | $13.56M | 58,185 |
| Amgen Inc.AMGN | 1.77% | $13.54M | 35,158 |
| Incyte Corp.INCY | 1.76% | $13.46M | 112,625 |
| Becton, Dickinson and Co.BDX | 1.73% | $13.29M | 80,253 |
| DexCom, Inc.DXCM | 1.73% | $13.25M | 158,765 |
| AbbVie Inc.ABBV | 1.73% | $13.25M | 52,782 |
| Viatris Inc.VTRS | 1.72% | $13.22M | 752,689 |
| Revvity, Inc.RVTY | 1.72% | $13.18M | 117,173 |
| Cencora, Inc.COR | 1.71% | $13.13M | 42,185 |
| Steris PLCSTE | 1.70% | $13.03M | 57,066 |
| Insulet Corp.PODD | 1.70% | $13.03M | 78,813 |
| Merck & Co., Inc.MRK | 1.69% | $12.97M | 99,646 |
| Vertex Pharmaceuticals Inc.VRTX | 1.69% | $12.97M | 27,186 |
| ResMed Inc.RMD | 1.69% | $12.95M | 61,357 |
| Henry Schein, Inc.HSIC | 1.68% | $12.91M | 150,505 |
| McKesson Corp.MCK | 1.68% | $12.89M | 15,050 |
| Johnson & JohnsonJNJ | 1.67% | $12.78M | 49,845 |
| HCA Healthcare, Inc.HCA | 1.67% | $12.77M | 31,727 |
| Invesco Private Prime FundCash or money market | 1.66% | $12.76M | 12,754,803 |
| Gilead Sciences, Inc.GILD | 1.66% | $12.72M | 97,666 |
| Cooper Cos., Inc. (The)COO | 1.65% | $12.69M | 175,449 |
| GE HealthCare Technologies Inc.GEHC | 1.65% | $12.66M | 186,109 |
| CVS Health Corp.CVS | 1.65% | $12.65M | 121,120 |
| Zimmer Biomet Holdings, Inc.ZBH | 1.65% | $12.65M | 134,627 |
| Medtronic PLCMDT | 1.65% | $12.63M | 147,910 |
| Cardinal Health, Inc.CAH | 1.65% | $12.63M | 54,900 |
| Danaher Corp.DHR | 1.64% | $12.59M | 64,594 |
| Solventum Corp.SOLV | 1.63% | $12.54M | 146,743 |
| Stryker Corp.SYK | 1.63% | $12.50M | 38,366 |
| Agilent Technologies, Inc.A | 1.63% | $12.48M | 90,207 |
| Biogen Inc.BIIB | 1.62% | $12.41M | 61,162 |
| Waters Corp.WAT | 1.61% | $12.34M | 32,715 |
| West Pharmaceutical Services, Inc.WST | 1.59% | $12.22M | 35,828 |
| UnitedHealth Group Inc.UNH | 1.57% | $12.06M | 29,098 |
| Eli Lilly and Co.LLY | 1.57% | $12.05M | 10,490 |
| IDEXX Laboratories, Inc.IDXX | 1.56% | $11.95M | 21,369 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.